Dr. Komal Bagga

Currently working on development of ultrasensitive nano-functionalized bioassay platform for the early diagnosis of cervical cancer by detecting Human Papillomavirus (HPV) which is the causative agent for 99.7% of invasive cervical cancer. The proposed diagnostic platform design aims to address the limitations of existing diagnostic technologies and develop an alternative powerful detection method that will allow ultra-sensitive detection of HPV within a shorter time frame, at a higher resolution and at a lower cost.This project is funded by European Commission(EU) - Research and Innovation.